BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Accuray Inc. (ARAY) to Report Financial Results for Second Quarter Fiscal 2013


1/17/2013 7:04:33 AM

SUNNYVALE, Calif., Jan. 17, 2013 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company, today announced that it will report results for its second quarter of fiscal 2013, ended December 31, 2012 on Wednesday, February 6, 2013 after the market closes.

A conference call to review the results will begin at 2:00 p.m. PST/5:00 p.m. EST and will be hosted by Joshua H. Levine, president and chief executive officer and Derek Bertocci, senior vice president and chief financial officer.

The conference call dial-in numbers are 1-866-761-0749 (USA) or 1-617-614-2707 (International), Conference ID: 63591669. In addition, a dial-up replay of the conference call will be available beginning February 6, 2013 at 5:00 p.m. PST/8:00 p.m. EST and ending on February 13, 2013. The replay telephone number is 1-888-286-8010 (USA) or 1-617-801-6888 (International), Conference ID: 63531003.

A live webcast of the call will also be available from the Investor Relations section of the corporate website at http://www.accuray.com/investors. A webcast replay can be accessed on the corporate website beginning Wednesday, February 6, 2013 at approximately 5:00 p.m. PST/8:00 p.m. EST. The replay will remain available until Accuray announces its results for the third quarter of fiscal 2013, ending March 31, 2013.

About Accuray

Accuray Incorporated (Nasdaq: ARAY), is a radiation oncology company that develops, manufactures and sells personalized, innovative treatment solutions that set the standard of care with the aim of helping patients live longer, better lives. The Company's leading-edge technologies deliver the full range of radiation therapy and radiosurgery treatments. For more information, please visit www.accuray.com.

Contacts:

Investor Contact:

Tom Rathjen

Vice President, Investor Relations

+1 (408) 789-4458

trathjen@accuray.com

Media Contact:

Stephanie Tomei

Director, Corporate Communications

+1 (408) 789-4234

stomei@accuray.com

SOURCE Accuray Incorporated



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES